Talha Khan Burki. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/therapeutic useDisease-Free SurvivalHumansMalePhenylthiohydantoin/analogs & derivativesPhenylthiohydantoin/therapeutic useProstatic Neoplasms, Castration-Resistant/drug therapyTime Factors
Substances: See more » Antineoplastic AgentsPhenylthiohydantoinenzalutamide
Year: 2014 PMID: 25121180 DOI: 10.1016/s1470-2045(14)70251-7
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316